Healthcare -
Biotechnology - NASDAQ - US
$ 9.34
-2.91 %
$ 1.03 B
Market Cap
-3.77
P/E
COGT - COST OF REVENUE
Cost of Revenue COGT - Cogent Biosciences, Inc.
3.59 M
LAST VALUE
394.05%
2 YEAR CAGR
0.00%
5 YEAR CAGR
0.00%
10 YEAR CAGR